Farraye FA - Search Results

1

Rex DK, Anderson JC, Butterly LF, Day LW, Dominitz JA, Kaltenbach T, Ladabaum U, Levin TR, Shaukat A, Achkar JP, Farraye FA, Kane SV, Shaheen NJ. Rex DK, et al. Among authors: farraye fa. Gastrointest Endosc. 2024 Sep;100(3):352-381. doi: 10.1016/j.gie.2024.04.2905. Epub 2024 Aug 21. Gastrointest Endosc. 2024. PMID: 39177519 No abstract available.

2

Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials.

Yang MM, Usiskin K, Ahmad HA, Ather S, Sreih A, Canavan JB, Farraye FA, Ma C. Yang MM, et al. Among authors: farraye fa. Dig Dis. 2024;42(1):12-24. doi: 10.1159/000533395. Epub 2023 Sep 27. Dig Dis. 2024. PMID: 37757769 Free PMC article. Review.

3

Radiographically-Measured Sarcopenia Predicts Hospitalization in Patients With Crohn's Disease.

Bali AS, El Sheikh WG, Ouni A, Kwon J, Moktan V, Chen F, Farraye FA, Tamim H, Hashash JG. Bali AS, et al. Among authors: farraye fa. J Clin Gastroenterol. 2026 Jan 20. doi: 10.1097/MCG.0000000000002317. Online ahead of print. J Clin Gastroenterol. 2026. PMID: 41564027

4

Pneumococcal Vaccine Is Associated with Improved Outcomes in Inflammatory Bowel Disease: Insights from a Propensity-Matched Study in the United States.

Mohamed MFH, Gupta SR, Beran A, Hamid O, Farraye FA, Shah SA. Mohamed MFH, et al. Among authors: farraye fa. Dig Dis Sci. 2026 Jan 10. doi: 10.1007/s10620-025-09653-0. Online ahead of print. Dig Dis Sci. 2026. PMID: 41518450

5

Abnormal MUC1 Expression as a Biomarker for Pouchitis.

Olson CG, Francis FF, Yan IK, Nakhleh R, Tamim H, Camilleri M, Kurdi A, Farraye FA, Hashash JG. Olson CG, et al. Among authors: farraye fa. Dig Dis Sci. 2025 Dec 21. doi: 10.1007/s10620-025-09612-9. Online ahead of print. Dig Dis Sci. 2025. PMID: 41422478

6

Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis.

Desai A, Habib H, Khataniar H, Farraye FA, Sehgal P, Barnes EL, Kochhar GS, Hashash JG. Desai A, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2025 Dec 9:izaf301. doi: 10.1093/ibd/izaf301. Online ahead of print. Inflamm Bowel Dis. 2025. PMID: 41365321

7

Risk of Incident Immune-Mediated Inflammatory Diseases with Second Tumor Necrosis Factor Inhibitor Versus Alternative Biologic Therapy in Patients with Inflammatory Bowel Disease and First TNFi Exposure: A Real-World Cohort Study.

Desai A, Kochhar GS, Khataniar H, Hashash JG, Farraye FA. Desai A, et al. Among authors: farraye fa. Dig Dis Sci. 2025 Dec 9. doi: 10.1007/s10620-025-09598-4. Online ahead of print. Dig Dis Sci. 2025. PMID: 41364352

8

Evaluating Choice of Biologics for Isolated Small-Bowel Crohn's Disease.

Tome J, Alsakarneh S, Hashash JG, Farraye FA, Pardi DS. Tome J, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2025 Dec 3:izaf294. doi: 10.1093/ibd/izaf294. Online ahead of print. Inflamm Bowel Dis. 2025. PMID: 41338240

9

Risk of Intestinal and Extraintestinal Malignancies in Inflammatory Bowel Disease With and Without Primary Sclerosing Cholangitis.

Al Ta'ani O, Alsakarneh S, Shaukat A, Farraye FA, Hashash JG, Francis FF. Al Ta'ani O, et al. Among authors: farraye fa. Dig Dis Sci. 2025 Dec 2. doi: 10.1007/s10620-025-09593-9. Online ahead of print. Dig Dis Sci. 2025. PMID: 41329382

10

The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists.

Susiriwatananont T, Eiamprapaporn P, Vazquez Roque M, Farraye FA, Perlman A, Chumsri S. Susiriwatananont T, et al. Among authors: farraye fa. Cells. 2025 Nov 12;14(22):1779. doi: 10.3390/cells14221779. Cells. 2025. PMID: 41294832 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters